Nicotinell Spearmint (Nicotine Polacrilex)

Nicotine polacrilex is a polymer‑bound form of nicotine that releases the active ingredient onto the oral mucosa. The nicotine binds to nicotinic acetylcholine receptors, producing mild stimulation that mimics the nicotine levels from smoking, thereby reducing cravings and withdrawal discomfort.

The specific dose and duration of Nicotinell Spearmint are determined by the prescribing healthcare professional based on the individual’s smoking history, level of dependence, and overall health. Patients should follow the prescriber’s instructions and not exceed the recommended amount.

Safety in pregnancy or while breastfeeding has not been fully established. Women who are pregnant, planning to become pregnant, or nursing should discuss potential risks and benefits with their healthcare provider before using any nicotine replacement product.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nicotinell Spearmint delivers nicotine via an oromucosal lozenge, offering a discreet, non‑inhaled alternative to patches, gums, or inhalers. Its spearmint flavor may improve tolerability for some users, while the lozenge format allows flexible dosing compared with fixed‑dose patches.

Store Nicotinell Spearmint at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

The lozenge is placed in the mouth and allowed to dissolve slowly, allowing nicotine to be absorbed through the oral mucosa. Users should avoid chewing or swallowing the lozenge whole and should follow the prescriber’s guidance on frequency and timing.

Serious risks, though rare, include severe allergic reactions such as throat swelling, difficulty breathing, or anaphylaxis, as well as persistent chest pain or palpitations. Any of these symptoms require immediate medical attention.

Individuals with known hypersensitivity to nicotine polacrilex or any component of the lozenge should avoid use. It is also contraindicated for people who have recently experienced a heart attack, uncontrolled hypertension, or who are using other nicotine‑containing products without medical supervision.